Cytokines and anaemia in human immunodeficiency virus infection

Cytokines, Cellular and Molecular Therapy

Volumn 3, Issue 3, 1997, Pages 179-186

  Means Jr , Robert T ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anaemia; Human immunodeficiency virus; Interferon; Interleukin 1; Tumor necrosis factor

Indexed keywords

CYTOKINE; ERYTHROPOIETIN; INTERLEUKIN 1; IRON; RECOMBINANT ERYTHROPOIETIN; TUMOR NECROSIS FACTOR; ZIDOVUDINE;

ANEMIA; BONE MARROW CELL; CHRONIC DISEASE; ERYTHROID CELL; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IRON METABOLISM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW;

ANEMIA; CYTOKINES; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; HIV INFECTIONS; HUMANS; INTERFERONS; INTERLEUKIN-1; IRON; TUMOR NECROSIS FACTOR-ALPHA;

EID: 9844222491     PISSN: 13684736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Frontiera M, Myers AM, Peripheral blood and bone marrow abnormalities in the acquired immunodefi-ciency syndrome. West J Med (1987) 147: 157-60.
2. Zon LI, Arkin C, Groopman JE, Hematologic manifestations of the human immune deficiency virus (HIV). Br J Haematol (1987) 66: 251-6.
3. Richman DD, Fischl MA, Grieco MH et al, The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 317: 192-7.
4. Lee GR, The anemia of chronic disease. Semin Hematol (1983) 20: 61-80.
5. Cash JM, Sears DA, The spectrum of diseases associated with the anemia of chronic disease: a study of 90 cases. Am J Med (1990) 87: 638-44.
6. Baer AN, Dessypris EN, Krantz SB, The pathogenesis of anemia in rheumatoid arthritis. A clinical and laboratory analysis. Semin Arthritis Rheum (1990) 14: 209-23.
7. Miller RK, Altz-Smith M, Usefulness of serum ferritin in detecting iron deficiency in rheumatoid arthritis (RA). Arthritis Rheum (1982) 25: S114.
8. Jefferey MR, Some observations on anemia in rheumatoid arthritis. Blood (1953) 8: 502-18.
9. Tracey KJ, Vlassara H, Cerami A, Cachectin/tumor necrosis factor. Lancet (1988) i: 1122-5.
10. Brenner MK, Annotation: tumor necrosis factor. Br J Haematol (1988) 69: 149-52.
11. Beutler B, Cerami A, Cachectin: more than a tumor necrosis factor. N Engl J Med (1987) 316: 379-85.
12. Durum SK, Schmidt JA, Oppenheim JJ, Interleukin 1: an immunological perspective. Ann Rev Immunol (1985) 3: 263-87.
13. Dinarello CA, Interleukin-1 and its biologically related cytokines. Adv Immunol (1989) 44: 153-205.
14. Vilcek J, Gray PW, Rinderknecht E, Sevastopoulos CG, Interferon γ: a lymphokine for all seasons. Lymphokines (1985) 11: 1-32.
15. Murray HW, Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Intern Med (1988) 108: 595-608.
16. Hooks JJ, Moutsopopoulos HM, Geis SA et al, Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med (1979) 301: 5-8.
17. Maury CPJ, Andersson LC, Teppo A-M et al, Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1β concentration in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukemia (HEL) cells in vitro. Ann Rheum Dis (1988) 47: 972-8.
18. Balkwill F, Burke F, Talbot D et al, Evidence for tumor necrosis factor/cachectin production in cancer. Lancet (1987) 88: 1229-32.
19. Teppo A-M, Maury CPJ, Radioimmunoassay of tumor necrosis factor in serum. Clin Chem (1987) 33: 2024-7.
20. Mauritz NJ, Holmdahl R, Jonsson R et al, Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum (1988) 31: 1297-303.
21. Blick M, Sherwin SA, Rosenblum M, Gutterman J, Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res (1987) 47: 2986-9.
22. Vadhan-Raj S, Al-Katib A, Bhulla R et al, Phase I trial of recombinant interferon gamma in cancer patients. J Clin Oncol (1986) 4: 137-46.
23. Elliott MJ, Maini RN, Feldmann M et al, Randomised double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet (1994) 344: 1105-10.
24. Cartwright GE, The anemia of chronic disease. Semin Hematol (1966) 3: 351-75.
25. Means RT, Krantz SB, Progress in understanding the pathogenesis of the anemia of chronic disease. Blood (1992) 80: 1639-47.
26. Salvarini C, Casali B, Salvo D et al, The role of interleukin 1, erythropoietin, and red cell bound immunoglobulins in the anaemia of rheumatoid arthritis. Clin Exp Rheumatol (1991) 9: 241-46.
27. Moldawer LL, Marano MA, Wei H et al, Cachectin/tumor necrosis factor alters red blood cell kinetics and induces anemia in vivo. FASEB J (1989) 3: 1637-43.
28. Erslev AJ, Wilson J, Caro J, Erythropoietin titers in anemic, nonuremic patients. J Lab Clin Med (1987) 109: 429-33.
29. Baer AN, Dessypris EN, Goldwasser E, Krantz SB, Blunted erythropoietin response to anaemia in rheumatoid arthritis. Br J Haematol (1987) 66: 559-64.
30. Miller CB, Jones RJ, Piantadosi S et al, Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med (1990) 322: 1689-92.
31. Faquin WC, Schneider TJ, Goldberg MA, Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood (1992) 79: 1987-94.
32. Jelkmann W, Pagel H, Wolff M, Fandrey J, Monokines inhibiting erythropoietin production in human hepatoma cultures and in isolated perfused rat kidneys. Life Sci (1991) 50: 301-8.
33. Tracey KJ, Wei H, Nanogue KR et al, Cachectin/ tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med (1988) 167: 1211-27.
34. Roodman GD, Bird A, Hutzler D, Montgomery W, Tumor necrosis factor-alpha and hematopoietic progenitors: effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, HEL cells. Exp Hematol (1987) 15: 928-35.
35. Johnson CS, Cook CA, Furmanski P, In vivo suppression of erythropoiesis by tumor necrosis factor-α (IFN-α): reversal with exogenous erythropoietin (EPO). Exp Hematol (1990) 18: 109-13.
36. Johnson RA, Waddelow TA, Caro J et al, Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood (1989) 74: 130-8.
37. Maury CPJ, Anaemia in rheumatoid arthritis: role of cytokines. Scand J Rheumatol (1987) 18: 3-5.
38. Johnson CS, Keckler DJ, Topper MI et al, In vivo hematopoietic effect of recombinant interleukin-1 (alpha) in mice: stimulation of granulocytic, monocytic, megakaryocytic, and early erythroid progenitors; suppression of late stage erythropoiesis, and reversal of erythroid suppression with erythropoietin. Blood (1989) 73: 678-83.
39. Mamus SW, Beck-Schroeder SK, Zanjani ED, Suppression of normal human erythropoiesis by gamma interferon in vitro: role of monocytes and T-lymphocytes. J Clin Invest (1985) 75: 1496-503.
40. Raefsky EL, Platanias LC, Zoumbos NC, Young NS, Studies of interferon as a regulator of hematopoietic cell proliferation. J Immunol (1985) 135: 2507-12.
41. Zanjani ED, McGlave PB, Davies SF et al, In vitro suppression of erythropoiesis by bone marrow adherent cells from some patients with fungal infection. Br J Haematol (1982) 50: 479-90.
42. Sugimoto M, Wakabayashi Y, Hirose S-I, Takaku F, Immunological aspects of the anemia of rheumatoid arthritis. Am J Hematol (1987) 25: 1-11.
43. Broxmeyer HE, Williams DE, Lu L et al, The suppressive influences of tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-γ. J Immunol (1986) 136: 4487-95.
44. Denz H, Fuchs D, Huber P et al, Association between serum neopterin and ferritin in patients with haematologic neoplasias. Pteridines (1990) 2: 120-4.
45. Alvarez-Hernandez X, Liceaga J, McKay IC, Brock JH, Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest (1989) 61: 319-22.
46. Rogers J, Durmowicz G, Kasschau K et al, A motif within the 5′ non-coding regions of acute phase mRNA mediates control of ferritin translation by IL-1β and may contribute to the anemia of chronic disease. Blood (1991) 78(Suppl 1): 361a.
47. Spivak JL, Barnes DC, Fuchs E, Quinn TC, Serum immunoreactive erythropoietin in HIV-infected patients. J Am Med Assoc (1989) 261: 3104-7.
48. Wang Z, Goldberg MA, Scadden DT, HIV-1 suppresses erythropoietin production in vitro. Exp Hematol (1993) 21: 683-8.
49. Fischl M, Galpin JE, Levine JD et al, Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med (1990) 322: 1488-93.
50. Means RT, Olsen NJ, Krantz SB et al, Treatment of the anemia of rheumatoid arthritis with recombinant human erythropoietin: clinical and in vitro studies. Arthritis Rheum (1989) 32: 638-42.
51. Pincus T, Olsen NJ, Russell IJ et al, Multicenter study of recombinant human erythropoietin in correction of anemia in rheumatoid arthritis. Am J Med (1990) 89: 161-81
52. Fuchs D, Zangerle R, Artner-Dworzak E et al, Association between immune activation, changes of iron metabolism, and anaemia in patients with HIV infection. Eur J Haematol (1993) 50: 90-4.
53. Re MC, Zauli G, Furlini G et al, The impaired number of circulating granulocyte/macrophage progenitors in human immunodeficiency virus type-1 correlates with an active HIV-1 replication. Arch Virol (1993) 129: 53-64.
54. Stella CC, Ganser A, Hoelzer D, Defective in vitro growth of the hemopoietic progenitor cells in the acquired immunodeficiency syndrome. J Clin Invest (1987) 80: 286-93.
55. + progenitor cells from asymptomatic patients are not a major reservoir for human immunodeficiency virus-1. Blood (1995) 86: 1749-56.
56. + cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol (1993) 85: 20-4.
57. Davis BR, Marx JC, Johnson CE, et al, Absent or rare HIV infection of bone marrow stem/progenitor cells in vivo. J Virol (1991) 65: 1985-90.
58. + hematopoietic progenitor cells are not a major reservoir of the human immunodeficiency virus. Blood (1990) 76: 1281-6.
59. Molina JM, Scadden DT, Sakaguchi M et al, Lack of evidence for infection of or effect on growth of hematopoietic progenitor cells after in vivo or in vitro exposure to human immunodeficiency virus. Blood (1990) 76: 2476-82.
60. Karcher DS, Frost AR, The bone marrow in human immunodeficiency virus (HIV) related disease. Morphology and clinical correlation. Am J Clin Pathol (1991) 95: 63-71.
61. Lee MH, Means RT, Extremely elevated serum ferritin levels in a university hospital: associated diseases and clinical significance. Am J Med (1995) 98: 566-71.
62. Junca J, Olive A, Batlle M, Ferritinemia y enfermedad de Still. Rev Esp Reumatol (1993) 20: 66.
63. Blumberg BS, Hann H-WL, Mildvan D et al, Iron and iron binding proteins in persistent generalized lymphadenopathy and AIDS. Lancet (1984) i: 347.
64. Wickramasinghe SN, Beatty C, Shiels S et al, Ultrastructure of the bone marrow in HIV infection: evidence of dyshaemopoiesis and stromal cell damage. Clin Lab Haematol (1992) 14: 213-29.
65. Steinberg HN, Anderson J, Crumpacker CS, Chatis PA, HIV infection of the BS-1 human stroma cell line: effect on murine hematopoiesis. Virology (1993) 193: 524-7.
66. Moses AV, Williams S, Henevald ML et al, Human immunodeficiency virus infection of bone marrow endothelium reduces induction of stromal hematopoietic growth factors. Blood (1996) 87: 919-25.
67. Balleari E, Timitilli S, Puppo F et al, Impaired in vitro growth of peripheral blood hematopoietic progenitor cells in HIV-infected patients: evidence of an inhibitory effect of autologous T lymphocytes. Ann Hematol (1991) 63: 320-5.
68. Gascon P, Sathe SS, Rameshwar P, Impaired erythropoiesis in the acquired immunodeficiency syndrome with disseminated Mycobacterium avium complex. Am J Med (1993) 94: 41-8.
69. Donahue RE, Johnson MM, Zon LI et al, Suppression of in vitro haematopoiesis following human immunodeficiency virus infection. Nature (1987) 326: 200-3.
70. Wright SC, Jewett A, Mitsuyasu R, Bonavida B, Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients. J Immunol (1988) 141: 99-104.
71. Molina J-M, Scadden DT, Byrn R et al, Production of tumor necrosis factor α and interleukin 1β by monocytic cells infected with human immunodeficiency virus. J Clin Invest (1989) 84: 733-7.
72. Kalinkovich A, Engelmann H, Harpaz N et al, Elevated serum levels of soluble tumor necrosis factor receptors (sTNF-R) in patients with HIV infection. Clin Exp Immunol (1992) 89: 351-5.
73. Cope AP, Aderka D, Doherty M et al, Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases. Arthritis Rheum (1992) 35: 1166-9.
74. Aderka D, Engelmann H, Maor Y et al, Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med (1992) 175: 323-9.
75. Maury CPJ, Lahdevirta J, Correlation of serum cytokine levels with haematological abnormalities in human immunodeficiency virus infection. J Intern Med (1990) 227: 253-7.
76. Means RT, Dallalio G, North M, Marrow cytokine levels in anemic patients with HIV (abstr). Blood (1995) 86(Suppl 1): 559a.
77. Lepe-Zuniga JL, Mansell PWA, Hersh EM, Idiopathic production of interleukin-1 in acquired immune deficiency syndrome. J Clin Microbiol (1987) 25: 1695-700.
78. Berman MA, Sandborg CI, Calabia BS et al, Interleukin-1 inhibitor masks high interleukin 1 production in acquired immunodeficiency syndrome (AIDS). Clin Immunol Immunopathol (1987) 42: 133-40.
79. Roux-Lombard P, Aladjem D, Balavoine J-F et al, Altered functions of peripheral blood monocytes in homosexual males and intravenous drug users with persistent generalized lymphadenopathy. Eur J Clin Invest (1986) 16: 262-70.
80. Murray HW, Rubin BY, Masur H, Roberts RB, Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med (1984) 310: 883-9.
81. Griffin DE, McArthur JC, Cornblath DR, Neopterin and interferon gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology (1991) 41: 69-74.
82. Suter PM, Suter S, Girardin E et al, High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis. Am Rev Resp Dis (1992) 145: 1016-22.
83. + T cells. Science (1995) 270: 1811-15.
84. Premack BA, Schall TJ, Chemokine receptors: gateways to inflammation and infection. Nature Med (1996) 2: 1174-8.
85. + human hematopoietic progenitors. Exp Hematol (1996) 24: 1509-15.
86. Verfaillie CM, Chemokines as inhibitors of hematopoietic progenitors. J Lab Clin Med (1996) 127: 148-50.
87. Means RT, North M, Dallalio G, Bone marrow, but not serum, chemokine levels differ between healthy individuals and patients with acquired immunodeficiency syndrome (abstr). Blood (1996) 88(Suppl 1): 340a.
88. McKenzie SW, Dallalio G, North M et al, Serum chemokine levels in patients with non-progressing human immunodeficiency virus (HIV) infection. AIDS (1996) 10: F29-33.
89. Dallalio G, North M, Means RT, Inhibition of marrow CFU-E colony formation from human immunodeficiency virus-infected patients by β- and τ-interferon. Am J Hematol (1996) 53: 118-20.
90. Means RT, Dessypris EN, Krantz SB, Inhibition of human erythroid colony-forming units by interleukin-1 is mediated by gamma interferon. J Cell Physiol (1992) 150: 59-64.
91. Means RT, Krantz SB, Inhibition of human erythroid colony-forming units by tumor necrosis factor requires beta interferon. J Clin Invest (1993) 91: 416-19.
92. Means RT, Krantz SB, Luna J et al, Inhibition of murine erythroid colony formation in vitro by gamma interferon and correction by interferon inhibitor. Blood (1994) 83: 911-15.